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A B S T R A C T
Background: Deep brain stimulation of the anterior nucleus of the thalamus (ANT) is an emerging therapy
for refractory focal epilepsy. However, the most optimal target for stimulation has not been unambigu-
ously described.
Objective: In the present study, we investigated the correlation between the stimulation site and outcome
in order to deﬁne the optimal target for deep brain stimulation in refractory epilepsy.
Methods: The locations of 62 contacts used in 30 treatment attempts in 15 prospectively followed pa-
tients during a 5 year period were assessed. Treatment attempts were classiﬁed into responding and non-
responding trials using seizure reduction and side effect proﬁle as criteria. The locations of active contacts
were calculated with respect to mid-commissural point and visible borders of ANT in 3T MRI (ANT-
normalized coordinate system) aiming to minimize the confounding effect of individual variation in the
location and size of the ANT.
Results: Contacts in successful treatment trials were located signiﬁcantly more anterior and superior both
in AC–PC and ANT-normalized coordinate systems. Favourable outcome was observed at 3T MRI based
location of ANT but not at location predicted by Schaltenbrandt atlas sagittal data. Contacts used in suc-
cessful trials were at anterior aspect of the ANT complex evidenced by the ANT-normalized coordinate
system.
Conclusion: The anti-epileptic effect of anterior thalamic DBS may be dependent on stimulation site es-
pecially in the anterior to posterior axis. Extensive anatomical variation confounds severely the targeting
of ANT. Therefore, direct visualization of the desired target for stimulation is essential for favourable outcome
in refractory epilepsy.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Deep brain stimulation (DBS) of the anterior nucleus of the thala-
mus (ANT) was ﬁrst introduced by Cooper and Upton [1–4] followed
by several pilot studies reporting safety and potential eﬃcacy in re-
fractory epilepsy [5–10]. This pioneering workmotivated performing
a large scale controlled multicentre trial (SANTE trial) with a 29%
greater seizure reduction in the active stimulation group com-
pared to sham stimulation and a median of 56% seizure reduction
compared to baseline at 2 years [11]. Recent 5-year results of the
SANTE trial showed slightly improved outcome with a median of
69% seizure reduction [12]. Finally, favourable long-term eﬃcacy of
ANT-DBS was also reported by Lee et al. with a mean of 70% seizure
reduction [13].
Abbreviations: 3T, three tesla; 18-F-FDG-PET, 18-ﬂuoro-deoxyglucose-positron-
emissio-tomography; AC, anterior commissure; AM, anteromedial nucleus; ANT,
anterior nucleus of thalamus; Apr, anterior principal nucleus; DBS, deep brain stim-
ulation; IPG, internal pulse generator; MCP, midcommissural point; MRI, magnetic
resonance imaging; MTT, mamillo-thalamic tract; PC, posterior commissure; PTZ,
pentylenetetrazole; SANTE, stimulation of anterior nucleus of thalamus in epilep-
sy; SPSS, statistical package for social sciences; STIR, short tau inversion recovery;
SWA, Schaltenbrant–Wahren atlas; T1WI, T1 weighted image; T2WI, T2 weighted
image; VAT, volume of activated tissue; XR, relative X coordinate in ANT-normalized
coordinate system; YR, relative Y coordinate in ANT-normalized coordinate system;
ZR, relative Z coordinate in ANT-normalized coordinate system.
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The selection of ANT as a potential target nucleus for stimula-
tion was based on data suggesting crucial role for ANT in seizure
spread [14–17]. Available studies including the SANTE trial have
tested this hypothesis by assessing seizure reduction compared to
baseline after implantation of leads aiming at ANT. However, the
speciﬁc effect of active contact location on outcome has not been
addressed previously. Therefore, the speciﬁc anterior thalamic region
being responsible for the favourable outcome has not been unam-
biguously deﬁned.
The targeting method of choice for DBS depends largely on the
visualization of the target structure. Poor visualization of the desired
target in MRI encourages the use of indirect atlas based targeting
using stereotactic coordinates. Importantly, a high degree of ana-
tomical variation has been reported in the location of ANT in
stereotactic space in non-epileptic subjects [18]. We have recently
conﬁrmed this ﬁnding using 3T MRI in patients with epilepsy [19].
These data suggest that atlas based targeting may not be unques-
tionably feasible to ANT targeting. Fortunately, recent developments
in the imaging of the ANT suggest that ANT can be delineated using
3T MRI techniques visualizing the white matter structures envel-
oping ANT [19,20] enabling direct DBS targeting of ANT.
The present study investigates the relationship between the stim-
ulation site at ANT vicinity and outcome in patients with refractory
epilepsy. We speciﬁcally asked whether a region associated with
the most optimal outcome can be deﬁned in stereotactic space. Sec-
ondly, we tested whether a region of the most favourable outcome
can be directly deﬁned relative to visible ANT borders. Finally, we
sought for evidence suggesting that stimulation speciﬁcally at ANT
is more effective than stimulation of adjacent thalamic structures.
Materials and methods
Patients
A total of 15 patients underwent ANT-DBS for refractory epi-
lepsy. All patients were evaluated using inpatient video-EEG
telemetry, 18-F-FDG-PET and 3T MRI to identify potential epilep-
togenic zone/epileptic syndrome and evaluated for resective surgery.
Clinical features of the patients are summarized in Table 3. Study
plan was approved by the Ethical Committee of Tampere Univer-
sity Hospital.
Imaging
The MRI sequences obtained for surgical planning included sag-
ittal T1WIwith thin slices for multiplanar reconstruction, axial T2WI,
and STIR in all three orientations in majority of the patients [19].
All images were obtained using a 3T scanner (MAGNETOM Trio 3T,
Siemens Healthcare Sector, Erlangen, Germany) with a 12-channel
head matrix coil. The STIR sequence used was a 2D turbo inver-
sion recovery sequence with short inversion time (TR/TE/
TI = 8300 ms/22 ms/120 ms: acquisition time 7:05 minutes), with
a slice thickness/gap of 2.0/0.2 mm, matrix size 256 × 256 and FOV
of 235 mm.
During surgery, patients underwent stereotactic CT followed by
co-registration of the previously performed surgical plan. Few days
after surgery, patients underwent postoperative thin slice CT fol-
lowed by image fusion to the preoperative STIR images using Elekta
software (Elekta AB, Stockholm, Sweden).
Planning of the procedure
Surgical plan was performed using Elekta Surgiplan software. The
preliminary surgical target was at 5–6 mm lateral, 12 mm superi-
or and 0–2 mm anterior to MCP. The target was then individually
adjusted according to individual anatomy using the mamillo-
thalamic (mtt) tract as a landmark. The trajectory was planned to
run primarily transventricularly (24 out of 30) avoidingmajor visible
vascular structures in contrast enhanced T1 images. Paraventricular
trajectory was selected as a secondary option (6 out of 30) due to
rich ventricular veins. Paraventricular approach to the central part
of ANT was found to be challenging due to course of thalamo-
striatal vein at superior, lateral and anterior aspect of ANT. Keeping
inmind the hippocampal input to ANT viamtt, the trajectory in these
cases was planned to run at inferior–lateral aspect of ANT, aiming
to stimulate mtt–ANT junction.
Surgery
Surgery was performed under general anesthesia except patient
number 1. DBS electrodes (Medtronic 3387 in patient 1 and 3389
in consecutive 14 patients) were implanted via insertion cannula
extending 10 mm level above planned target under intra-operative
ﬂuoroscopy control and ﬁxed to the skull. Extension cables and Activa
PC (Medtronic) internal pulse generator (IPG) were implanted in the
same procedure.
Stimulation parameters
Stimulator was typically turned on in the ﬁfth postoperative day
using 1min ON and 5min OFF cycle, 140 Hz, 90 μs pulse width. The
stimulation amplitude was elevated to 5 V during a period from 5–6
postoperative days to 2–3 weeks. The initial contacts for cathodal
monopolar stimulation were selected by neurosurgeon using pre-
operative MRI–postoperative CT fusion images. Changes in active
contacts were later made due to lack of response or side effects
(Table 1). In one patient, bipolar stimulation was used due to im-
planted cardiac pacemaker.
Evaluation of the outcome
First 3 months after implantation were excluded from the anal-
ysis due to a potential lesion effect [11]. Contact pairs were classiﬁed
as a responding contact pair or non-responding contact pair using
a >50% reduction in seizure frequency and side-effect proﬁle as a
criteria. Seizure frequency assessment was based on patient’s seizure
diaries. An episode of status epilepticus or intolerable side-effects
during contact pair stimulation led to classifying the treatment trial
as a non-responding trial. Characteristics of the treatment trials and
therapy response are presented in Table 2.
Evaluation of contact locations
The locations of contacts relative to MCP were calculated from
postoperative CT–preoperative 3TMRI fusion images using FrameLink
software (Medtronic). Contact locations were superimposed onto
a sagittally oriented overlap model of left ANT delineations (n = 8)
based on 3T MRI STIR images described previously [19] to demon-
strate the relationship betweenmean contact locations with respect
to Schaltenbrant–Wahren atlas (SWA) [21] and 3T MRI based lo-
cation of ANT.
To evaluate the location of contacts with respect to boundaries
of ANT, a proportional coordinate system normalized to ANT di-
mensions was developed (Fig. 1). The relative coordinates of each
contact were then calculated in the ANT-normalized coordinate
system. In one patient (responder) the locations of contacts were
calculated only in AC–PC coordinate system due to lack of 3T MRI
images (cardiac pacemaker). In the case that no response was ob-
served using a particular contact pair but clear response was
observed after adding more cranial contacts bilaterally, the initial
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contacts were classiﬁed as non-responders and secondary con-
tacts as responders.
Statistical analysis
SPSS version 17.0 (IBM, Armonk, NY, USA) was used in statisti-
cal analysis. In patients without a change in response status (being
responder with all contacts tested or being non-responder with all
contacts tested) independent samples t-test was used to compare
mean location of contacts. In patients with a change in response
status (responsewith some contact pair and non-responsewith other
contact pair) paired samples t-test was used to compare mean lo-
cation of contacts.
Results
The locations of 62 contacts used in 30 treatment trialswere ana-
lyzed. Twenty-ﬁve contacts were associatedwith therapy response
and 37 contacts were non-responders. The mean duration of stim-
ulation in responding trials was 18.3 ± 12.9 months and the mean
Table 1
The contact combinations and therapy response.
Patient Contacts Seizure reduction Side effects Pre-DBS mean seizure interval Period duration Response
1 2/10 ≈50% 1.3 days 4 months Yes
1/9 ≈50% Psychiatric 1.4 years No
3/11 >50% 2.8 years Yes
2 2/10 NC <1 days 6 months No
1/9 NC Psychiatric 7 months No
0–1/8–9 NC Psychiatric 2 months No
3/11 NC 3.5 months No
3 2/10 >50% <1 days 3.3 years Yes
4 3/11 NC 1 days 1.5 years No
2/10 NC 5 months No
0/8 NC 4 months No
5 2/10 NC 3 days 3.5 months No
1/9 SE 2 weeks No
3/11 >50% 2.7 years Yes
6 2/10 NC <1 day 5 months No
3/11 NC 8 months No
7 3/11 >50% 1.7 days 2 years Yes
8 3/11 >50% <1 day 2.3 years Yes
9 2/10 NC <1 day 1.8 years No
3/11 >50% 7 months Yes
10 2/10 NC <2 day 2 years No
3/11 >50% 9 months Yes
11 3/10–11 >50% 15 days 1.7 years Yes
12 1/9 NC <2 day 1.3 years No
2/10–11 NC 5 months No
13 3/11 NC Obsessions 7.5 days 9 months No
14 2/10 >50% Confusion 2.5 days 4 months Yes
3/11 >50% 1 year Yes
15 2/10 NC 2 days 4 months No
2-3/11 >50% 6 months Yes
The relationship between active contacts, side-effects and response are presented together with the mean seizure interval and the duration of the treatment trials. The cu-
mulative duration of stimulation in whole patient group was 378 months (31.5 years). Contact combinations are shown in chronological order in each patient.
NC, no change; SE, status epilepticus.
Table 2
The mean location of contacts.
dezilamron-TNACP–CApuorG
X (mm ± SD) Y (mm ± SD) Z (mm ± SD) XR ± SD YR ± SD ZR ± SD
Response with initial contacts
Responding contacts (n = 3.5)31 ± 1.0 4.1 ± 1.1
***
11.6 ± 1.1 0.64 ± 0.33 0.65 ± 0.33 0.27 ± 0.29
No response using any of the contacts
Non-responding contacts (n = 7.3)52 ± 4.6 1.0 ± 2.5 9.6 ± 2.7 0.84 ± 0.45 0.39 ± 0.25 0.09 ± 0.31
Non-responder to responder after programming
Responding contacts (n = 6.5)21 ± 1.0
†
2.7 ± 1.7 12.9 ± 2.0 0.68 ± 0.32 0.62 ± 0.08 0.35 ± 0.30
Non-responding contacts (n = 8.4)21 ± 1.0 2.0 ± 2.0 11.1 ± 2.1 0.52 ± 0.29 0.48 ± 0.07 −0.04 ± 0.33
All
Responding contacts (n = 4.5)52 ± 1.0 3.4 ± 1.6 12.2 ± 1.7 0.66 ± 0.3 0.63 ± 0.2 0.31 ± 0.3
Non-responding contacts (n = 3.5)73 ± 1.7 1.4 ± 2.4 10.1 ± 2.6 0.73 ± 0.4 0.42 ± 0.2 0.05 ± 0.3
† †† ††
*
Two parallel analyses were performed to compare contact locations between responders and non-responders. Patients with therapy response using initial (and ﬁnal) con-
tacts were compared to patients without therapy response using any of the contacts tested (independent samples t-test, 2-tailed) and presented as (*p > 0.05; ***p < 0.001).
The location of contacts in patients who became responders after re-programming of the IPG was tested separately using paired samples t-test (2-tailed) and presented as
(†p < 0.05; ††p < 0.01; †††p < 0.001). We observed that responding contacts were signiﬁcantly more anterior and superior compared to non-responding contacts in patients
who became responders after re-programming of the IPG. Contacts in patients with initial response were also signiﬁcantly more anterior than in patients without response
using any of the contacts. We observed also a trend in more superior location of responding contacts in patients with initial response compared to non-responding con-
tacts in patients who did not beneﬁt any of the contacts tested (p = 0.09, independent sample’s t-test).
XR, relative X coordinate; YR, relative Y coordinate; ZR, relative Z coordinate; SD, standard deviation; AC, anterior commissure; PC, posterior commissure; ANT, anterior nucleus
of thalamus; IPG, internal pulse generator.
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durationof side-effect free non-responding trialwas 9.5 ± 7.5months.
The total duration of stimulatedperiodswas 378months (31.5 years).
Table 1 presents treatment trials in a chronological order for each
patient (baseline seizure frequency, responseandpotential side-effect).
A total of 10 patients out of 15 underwent stimulation usingmul-
tiple contact pairs. After changes in the active contacts, 10 patients
out of 15 (67%) became eventually responders. Six patients were
responders using the ﬁrst contact pairs, whereas 4 patients were
initially non-responders but were classiﬁed as responders after ac-
tivating the most proximal contacts at ANT. Two patients were
responders using the ﬁrst contact pair but better seizure control with
more favourable side effect proﬁle was observed after program-
ming more proximal contacts at ANT.
The patients were treated with antiepileptic drugs (AEDS) ac-
cording to standard clinical practice. At the time of ANT-DBS
treatment initiation one patient was on monotherapy, four pa-
tients on two AEDs, eight patients on three AEDs and two patients
on four AEDs reﬂecting the refractory nature of their epilepsy. During
the ANT-DBS treatment phase changes to their AED regiment were
done in 11 patients. AED changes were done in ﬁve patients due
to intolerable side-effects which lead to worsening of seizure control
in two patients with the remaining patients had unchanged seizure
frequency. In one patient one of her three AEDs was withdrawn due
to wishes of pregnancy leading to slight worsening of seizure control
with restoration of the same AED after pregnancy restoring the pre-
vious seizure frequency. In another patient carbamazepine dose was
unintentionally halved leading to worsening of seizure control. In
four patients in non-responding stage new AED treatment was ini-
tiated or dose of pre-existing AED increased with intention of
decreasing the seizures, none of these patients improved. In four
patients the AED treatment remained constant during the whole
follow-up period. AED changes were not responsible for the re-
sponder status in any of our patients.
Contact distribution in stereotactic space
Analysis of the contact locations revealed that the responding
contacts located signiﬁcantly more superior and anterior com-
pared to the non-responding contacts in AC–PC coordinate system
(Fig. 2A, Table 2). Patients without a change in their response status
showed signiﬁcantly more anterior responding contact locations
compared to non-responding contacts, whereas patients with a
change in their response status showed signiﬁcantly more superi-
or and lateral responding contact locations compared to non-
responding contacts.
A subgroup of eight patients underwent more detailed model-
ling of ANT delineations and used for demonstration of mean contact
locations together with MRI based variation of ANT location. The
distribution of the responding contacts matched closely to the most
frequently overlapped area in an overlap model of left ANT delin-
eations in 3T MRI, whereas the non-responding contacts were at
more posterior and inferior aspect of this area (Fig. 2A). Notewor-
thy, the mean location of non-responding contacts correlated highly
with location of ANT in SWA sagittal plates [21].
The location of contacts in ANT normalized coordinate system
To study whether responding contacts are located at some spe-
ciﬁc part of ANT complex, contact locations were calculated with
respect to visible boundaries of ANT using ANT normalized coor-
dinate system (Fig. 1). We found that responding contacts were
signiﬁcantly more anterior both in patients with or without a change
Figure 1. The principle of ANT normalized coordinate system. ANT normalized coordinate system is based on direct visualization of ANT in 3T STIR images. Sagittal (A) and
coronal (E) images from SWA are shown for comparison with 3T MRI STIR images (B–C, F–G). In ANT-normalized coordinate system the most posterior border of ANT is
deﬁned as 0 and most anterior border as 1 (D). The medial and inferior borders are deﬁned as 0 and the lateral and superior border as 1 in coronal image through the
mamillo-thalamic tract where ANT is most reliably visualized (H). The anterior–posterior axis of ANT-normalized coordinate system is oriented along AC–PC line and both
medial–lateral axis and inferior–superior axis are perpendicular to AC–PC line. Abbreviations: Apr, anterior principal nucleus; AM, anteromedial nucleus; VA, ventral an-
terior nucleus; Cd, nucleus caudatus; mtt, mamillo-thalamic tract, SWA, Schaltenbrandt–Wahren atlas. Printed with permission.
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in their response status (Fig. 2B, Table 2). Responding contacts were
signiﬁcantly more superior in patients with a change in response
status compared to non-responding contacts (Table 2). Fig. 2 dem-
onstrates the mean contact locations with respect to anatomical
relationships according to SWA.
When compared to the AC–PC coordinate system, we found that
the ANT normalized coordinate system was more robust in differ-
entiating responding and non-responding contacts especially in the
anterior–posterior axis (Fig. 3). Seventeen out of 23 (74%) respond-
ing contacts were located anterior to Y-axis cut-off level YR = 0.58,
whereas 30 out of 36 (83%) contacts posterior to this cut-off level
were classiﬁed as non-responders (for more details, see Fig. 3). Fur-
thermore, two non-responding contacts with Y-axis projected
location of contact at anterior part of ANT (anterior to YR = 0.58) were
implanted using paraventricular trajectory and had very lateral lo-
cation (XR = 1.4 and 1.5), thus being clearly lateral to ANT (Fig. 3).
Clinical characteristics and outcome
Table 3 summarizes the clinical characteristics and the most
optimal contact locations in individual patients together with clin-
ical characteristics. We observed no clear association between
patient’s age, sex, MRI pathology, seizure onset zone, aetiology or
previous epilepsy surgery and the clinical outcome. To further dem-
onstrate the effect of contact locations on outcome at individual
patient level we deﬁned the optimal contact location at anterior
aspect of ANT (ANTa) using the following relative coordinates in ANT-
normalized coordinate system: anterior to YR = 0.58 and medial to
XR < 1.25. We observed that seven out of ten responders had contact
at ANTa bilaterally and three patients out of ten responders had a
contact at ANTa at least on the other side. In non-responders (n = 5)
only one patient had contact at ANTa bilaterally and one patient had
contact at ANTa on the other side (Table 3).
Discussion
Detailed analysis of the contact locations in anterior thalamic
region was carried out to study the structure–function correlation
between stimulation site and anti-epileptic effect in refractory ep-
ilepsy. We speciﬁcally assessed whether the stimulated area
associated with a favourable outcome can be neuroanatomically
deﬁned in stereotactic space or relative to the borders of ANT to guide
targeting and postoperative programming to optimize outcome. We
were able to demonstrate that the contacts with an actual loca-
tion at the anterior aspect of ANT, as demonstrated by ANT-
normalized coordinate system, were associated with a favourable
outcome. On the other hand, contacts at a location suggested by the
SWA sagittal plates were situated at more posterior/inferior aspect
of ANT and were associated with a poor outcome. Due to limited
number of individual patients in our study, we were not able to
observe any association between aetiology, seizure onset zone, MRI
ﬁndings or demographic factors and outcome.
Figure 2. The mean location of responding and non-responding contacts in stereotactic space. The relationship between responding (red) and non-responding (blue) con-
tacts is presented with respect to SWA (sagittal image 5.5 mm lateral from midline) and 3T MRI based location of ANT [19]. Area overlapped by 1 out of 8 cross-sectional
models of ANT in 3T MRI in the left hemisphere is shown in light blue, area overlapped by 4 out of 8 cross-sectional models is shown in yellow and most frequently over-
lapped area (7 out of 8) cross-sectional models is shown in orange (2A). The responding contact location correlates highly with the most frequently overlapped area from
cross-sectional models from individual patients. The mean non-responding contact location correlates with the SWA sagittal information (black solid line in 2A). ANT-
normalized coordinate system reveals that responding contacts are located at the anterior aspect of ANT complex at the border between anterior principal nucleus (Apr)
and anteromedial nucleus (AM). Note the mean location of responding contacts slightly superior and anterior to mtt termination point. Circles indicate one standard de-
viation (SD) frommean values. Abbreviations: XR, relative X coordinate; YR, relative Y coordinate; ZR, relative Z coordinate; Apr, anterior principal nucleus; AM, anteriomedial
nucleus, SWA, Schaltenbrandt–Wahren atlas; sup, superior; ant, anterior; post, posterior; mtt, mamillo-thalamic tract. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.) Printed with permission.
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We found statistically signiﬁcant and systematic differences in
the contact locations between responding and non-responding con-
tacts. AC–PC coordinate system revealed approximately 2mmoverall
differences both in Y and Z coordinates between responding and
non-responding contacts (Table 2), resulting in approximately 2.9mm
difference in the sagittal plane. In the ANT-normalized coordinate
system we observed a mean of 0.21 and 0.26 unit difference in the
relative Y and Z coordinates respectively (Table 2). Using average
Figure 3. The robustness of ANT-normalized coordinate system compared to AC–PC coordinate system in the evaluation of responding and non-responding contact loca-
tions. The isolated Y coordinates of the responding (red) and non-responding (blue) contacts are shown in AC–PC coordinate system (upper panel) and in ANT-normalized
coordinate system (lower panel). AC–PC coordinate system shows marked Y coordinate overlap between responding and non-responding contacts whereas ANT-
normalized coordinate system shows more robust difference in responding and non-responding Y coordinates. Anterior to cut-off level YR = 0.58 (dashed line) 74% of the
contacts were responders whereas posterior to this level 83% of the contacts were non-responders. Two non-responding contacts (indicated by arrows) implanted using
paraventricular approach were at anterior aspect in the Y axis but due to lateral trajectory were clearly lateral to ANT (XR = 1.4 and 1.5). (For interpretation of the references
to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 3
The effect of MRI pathology, aetiology, previous epilepsy surgery and DBS lead location on outcome.
noitacoltcatnoctseBenoztesnoeruzieSygoloiteASNVIRMesnopseRegAxeStneitaP
Left Right
TNAlacofitluMDCoNaipotoretehlamydnepebuslaretaliblatipiccOseY23M1 a ANTa
TNAlacofitluMDCseYairygorcimylopnaivlysireplaretaliBseY82F3 a Post
TNAlacofitluMDCseYaipotoretehlaretaliblatipiccOseY23M5 a Post
TNAlacofitluMsitilahpecnEseYlamroNseY42M7 a ANTa
TNAlaropmetotnorfthgiRDCseYailahpecnegemimehthgiRseY83F8 a ** ANTa **
TNAlacofitluMsitilahpecnEseYsisoilgtaliblateirap-otnorFseY42F9 a ANTa
TNAlacofitluMsitilahpecnEoNlamroNseY23F01 a ANTa
TNAnwonknuedis,ebollatnorFknUoNlamroNseY84M11 a ANTa,
14 M 50 Yes Right temporal and frontal atrophy No Encephalitis Right temporal lobe ANTa Post
TNAlacofitluMDCseYairygorcimylopnaivlysireptaliBseY04M51 a ANTa
2 F 34 no CD left frontal lobe; left temporal resection No CD Left frontal lobe Post Post
tsoPtsoPlacofitluMsitilahpecnEseYlamroNoN32M4
TNAlacofitluMDCseYairygorcimylopnaivlysireptaliB*oN94M6 a Lat
fni/tsoPfni/tsoPlaropmetotnorftfeLsitilahpecnEseYlamroNoN42M21
TNAnwonknuedis,ebollatnorFknUseYlamroNoN44M31 a ANTa
Responders are shown at upper part of table (red rectangle) in a chronological order and non-responders at the bottom part of the table (blue rectangle) in a chronological
order. Cortical dysplasia and encephalitis were most common aetiologies both in responders and non-responders. Normal MRI was found in both groups. The deviation of
leads from anterior aspect of ANT (ANTa; deﬁned as anterior to YR = 0.58; medial to XR = 1.25) was the most evident factor explaining the lack of response.
* The patient number 6 had left sided lead at ANTa and showed reduction of most severe seizures. ** The patient had cardiac pacemaker and therefore only 1.5T MRI. The
patient number 13 had leads optimally at ANTa but was classiﬁed as a non-responder.
Post, posterior; inf, inferior; lat, lateral; CD, cortical dysplasia; unk, unknown; VNS, vagal nerve stimulation.
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ANT dimensions in 3T MRI (10 mm × 4 mm in Y and Z axes [19]),
this gives approximately 2.3 mm difference in the sagittal plane. In
the ﬁeld of DBS surgery these distances are generally regarded clin-
ically relevant. For instance, in DBS of subthalamic nucleus (STN),
such deviation from target is very likely to be associated with lack
of clinical effect.
The classical spherical model of current spread from DBS elec-
trode (volume of activated tissue (VAT)) is dependent on the
stimulation parameters but its radius is thought to be within a few
millimetre range. A matter of particular interest is the effect of white
matter structures at the posterior and inferior aspects of ANT sepa-
rating ANT, DM and VA nuclei. It may be speculated that relatively
small deviation from ANT into posterior/inferior direction could
prevent current spread into ANT by insulating white matter layers
to activate suﬃcient number of ANT neurons. Interestingly, this hy-
pothesis is supported by recent report using posterior trajectory to
ANT together with hippocampal DBS capable of registering of evoked
potentials [22]. They implanted electrodes along the posterior–
anterior axis of ANT and found that only the most anterior contacts
within ANT caused hippocampal evoked potentials while more pos-
terior contacts did not. They also reported favourable effect in these
two patients, although follow up was relatively short.
Our data suggest that stimulation at the anterior part of ANT
complex has powerful anti-epileptic effect. It is conceivable that stim-
ulation site at the anterior part of ANT complexmodulates the critical
nodes in the seizure propagation pathways. In fact, experimental
evidence suggests that ANT plays a major role in seizure spread and
generalization in pentylenetetrazole (PTZ)model in rats [16,23]. Stim-
ulation at anterior aspect of ANT using currently available DBS
devices reaches most likely the anteriomedial (AM) and the ante-
rior principal (Apr) subnuclei (Fig. 2B). AM has well established
connections to frontal cortex, anterior cingulum, retrosplenial cortex,
amygdala and hippocampus [24], while Apr is particularly well con-
nected to hippocampal area and posterior cingulum [24,25].
Furthermore, studies tracking axonal transport have demon-
strated that AM has connections to orbitofrontal, frontopolar and
medial prefrontal cortex in rhesus monkeys [26] and in rodents [27].
AM has also connections to amygdala, hippocampus, temporal lobe
cortex and mamillary bodies in rhesus monkeys [28]. In the light
of our results, it is attractive to hypothetize that stimulation at more
anterior aspect of ANT complex, presumably extending also to AM
subnucleus, may have capacity to modulate more broad range of
epileptic networks involving frontal and temporal lobe structures.
Pre-SANTE pilot studies reported 14–76% seizure reduction in
a relatively small number of patients [5–10]. These studies are subject
to several reviews [29–33]. SANTE trial reported median of 56%
seizure reduction in a group of 81 patients at 2 years with a 54%
responder rate (>50% seizure reduction) [11] and 69% seizure re-
duction with 68% responder rate at 5 years [12]. Lee et al. reported
results from chronic stimulation in 15 patients, where 80% of pa-
tients reached >50% seizure reduction level [13]. Our data are
consistent with these available studies with respect to the re-
sponder rate (68%). Importantly, our primary scope is entirely
different from these previous studies: We aimed to study and deﬁne
the most optimal target for DBS at anterior thalamus using outcome
data instead of assessing outcome in the individual patients with
DBS aimed at ANT. As a contrary, we have evaluated the response
for stimulation focusing on detailed analysis of individual contact
locations in multiple treatment trials. Post-hoc analysis of the lead
locations in individual patients showed that a lead location devi-
ating from most optimal target area deﬁned in the present study
(anterior aspect of ANT) was associated with poor outcome (Table 3),
being the only identiﬁable factor differentiating responders from non-
responders. A total of six patients improved after activation of the
most cranial contacts at ANT, indicating that contact location plays
a critical role in therapy outcome, and that a signiﬁcant improve-
ment can be achieved after re-programming of the device after
relatively long periods of time.
There is ongoing debate about the most optimal trajectory to the
ANT among neurosurgical centres currently performing this pro-
cedure. Available literature describes transventricular approach to
ANT [6,8,11,13]. However, several functional neurosurgeons expe-
rience this approach susceptible to lead misplacement due to
penetration of the lateral ventricle, or susceptible to intraventricu-
lar bleeding due to choroidal plexus vessels, and prefer
transparenchymal lateral approach to reach ANT. In the present study,
6 electrodes were implanted using paraventricular trajectory (bi-
laterally in two patients) whereas 24 electrodeswere implanted using
transventricular trajectory. Importantly, none of the contacts im-
planted paraventricularly was clearly at the ANT. It is vitally
important to understand that the most optimal trajectory is highly
dependent on the deﬁnition of the target. Trajectory to the indi-
rect ANT target using atlas based coordinates using tranventricular
trajectory from routine pre-coronal entry point most likely tra-
verses ANT with a relatively high success rate. However, the lateral
paraventricular approach may reach the identical “surgical” target
point, but due to a more lateral course of the electrode, may not
traverse ANT properly. Therefore, it is important to acknowledge that
surgery performed in the absence of clearly deﬁned neuroanatomi-
cal target, and using indirect targeting method (especially based on
SWA sagittal plates) together with lateral paraventricular ap-
proach, may be very potent cause of inconsistent results.
Furthermore, lateral paraventricular trajectory results in extreme-
ly lateral entry point and most likely penetration of the eloquent
cortex. One patient with bilateral lateral paraventricular approach
showed cortical infarct together with aphasia postoperatively which
eventually recovered. It may be speculated that lateral paraventricular
approach is not only less feasible in reaching optimal stimulation
site but also may have increased risk for neuronal deﬁcits.
Indirect targeting method is a remnant of the stereotactic tech-
nique used in the ventriculography era, but it is still widely used
with success especially in themovement disorder targets. While DBS
for movement disorders is performed only to patients with rela-
tively undisturbed brain MRI, this requirement is not realistic in a
patient group suffering from refractory epilepsy. The patient group
in the need of more effective form of therapy such as DBS consists
both from developmental and acquired lesions like cortical dyspla-
sia or various postoperative states severely disturbing the architecture
of the brain. Our data strongly suggest that stereotactic coordi-
nates should be used cautiously, and corrections should be made
according to individual patient’s anatomy.
Several experimental studies support our ﬁnding that stimula-
tion speciﬁcally at the ANT is essential for the antiepileptic effect.
Mirski et al. showed that high frequency stimulation of ANT had
an anti-epileptic effect in a PTZ seizure model in rats by increas-
ing seizure threshold level via serotonergic mechanism [34]. Rats
with stimulating electrode outside ANT (including dorsomedial
nucleus and ventral thalamic nucleus) showed seizure threshold level
similar to non-ANT-stimulation group [34]. Stimulation of the
dorsomedial nucleus lying at posterior–inferior aspect of ANT was
not antiepileptic in a kindling model of epilepsy [35]. In a study by
Stypulkowski et al., authors observed powerful inhibitory effect upon
hippocampal electrical activity using most cranially located con-
tacts at ANT, whereas adjacent more deeply located contact was not
associated with suppression of neuronal activity [36]. Hamani et al.
reported in pilocarpine model of SE in rats that the latency for SE
onset was increased after stimulation of all different subnuclei in
ANT complex (anteromedial, anterior principal and anterior
dorsal nucleus) [37]. Finally, in an earlier study by Mirski et al.,
behavioural seizure scores were decreased with high frequency ANT
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stimulation compared to stimulation at striatum or posterior thala-
mus in a PTZ model in rat [17].
Conclusions
Our data demonstrate that contact locationmay be a critical factor
determining therapy response in refractory epilepsy. Present study
provides further evidence for proof of principle in ANT-DBS and offers
new insight into the deﬁnition of the most optimal DBS target at
the anterior aspect of ANT in refractory epilepsy. Our results high-
light the importance of direct targeting based on individual patient’s
anatomy in ANT targeting.
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